Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Phase 3
Recruiting
- Conditions
- Ovarian Cancer
- Interventions
- Drug: Gleolan
- First Posted Date
- 2023-04-07
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- NX Development Corp
- Target Recruit Count
- 170
- Registration Number
- NCT05804370
- Locations
- 🇺🇸
Luminis Health Anne Arundel Medical Center, Annapolis, Maryland, United States
Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma
Phase 3
Completed
- Conditions
- Meningioma
- Interventions
- Drug: Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI)
- First Posted Date
- 2020-03-12
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- NX Development Corp
- Target Recruit Count
- 108
- Registration Number
- NCT04305470
- Locations
- 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States
🇺🇸University of California San Diego, La Jolla, California, United States
🇺🇸Keck Hospital of USC, Los Angeles, California, United States
News
No news found